Tony Acciarito, president of Thermo Fisher Scientific China

A1Thermo Fisher has a 500-squaremeter booth at the Medical Equipment & Health Care Products Hall, showcasing around 30 products serving different vertical industries like healthcare, pharma & biopharma, environment and food safety.

We have established a quick testing station that provides a hands-on experidrive for visitors to experience how our product impacts on real life. There’s also a virtual reality zone in the lab that enable visitors to access our advanced technology in real time.

What we really show our partners, customers and the China market is that Thermo Fisher has capabilities in innovation, and we innovate “in China for China”.

A2We are scheduled to have around 10 memorandum of understanding signing on the week including academia, pharma and biopharma, metal detection.

We have a number of companies (mostly Chinese) that we are using this expo to attract.

From organization perspective, we are looking forward to working with local government organizations, research institutes, universities, hospitals as well as companies.

From industry perspective, we expect procures from our key-focused vertical markets including healthcare, food safety, environmental as well as pharma and biopharma.

A3The CIIE is a significant move for the Chinese government to actively open the Chinese market to the world. For Thermo Fisher, China is a critical market.

Our priority in Chinese market is to help our customers to accelerate their innovation and to actualize the blueprint of “Healthy China 2030” by providing multiple solutions in precision medicine, environment and food safety, and etc.

At the same time, the CIIE provides an open platform to better understand the China market. With abundant industry resources, the CIIE will definitely help us to better understand the local needs and ensure our innoence vative solutions and technologies work for the Chinese market.

A4The reform and opening-up has created a huge market and enormous demand especially for industrial products. Thanks to the opening-up, we have the opportunity to expand our footprint in China and become an organic part of China’s economy.

Today China is the second largest country by revenue for Thermo Fisher, representing 10 percent of total global revenue in 2017 and achieving double-digit growth.

We’ve been here for over 35 years.

We are here to celebrate the opening-up of China and we believe in the further opening-up as something that will create more opportunity for the Chinese market.

For instance, our key industrial focus includes precision medicine, digital and biopharma which are all aligned with government’s priorities.

A5I remain optimistic about the economy, because as we engage closely with customers, we find that there is a real need to want to work with us and that is my gauge of whether we’re going to be successful or not. And this is how the CIIE is a great forum for us to understand whether the companies actually see a need from us.

I think China has many promising markets to focus on, such as healthcare, environment, pharma and biopharma they are all growing fast.

And that tells me that the government is really investing in China for the long term, it’s not a short-term strategy.

I’m glad to see that our products and solutions align with them.